Skip to main content
Benaroya Research Institute at Virginia Mason logo.
Menu
  • News
  • Resources
  • Careers
  • Autoimmune Life Blog
  • Contact

Search form

  • What is BRI
    • About BRI
    • Immune System Diseases
    • Scientists & Laboratories
  • Research at BRI
    • Join Our Research
    • Track Our Clinical Research
    • Type 1 Diabetes Research
    • Centers of Discovery
    • Programs
    • Recent Publications
    • Collaborations
  • For Scientists
    • Programs
    • Core Labs
    • Principal Scientist Labs
    • Scientific Staff
    • Publications
  • For Industry
    • Contact Us
    • Business Development Team
    • Available Technologies
    • Industry Collaborations
    • Clinical Research Program -- for Sponsors
  • Support BRI
    • BRI Fundraising Events
    • Become a Champion
    • Ways to Give

Donate

You are here

Home

Carla Greenbaum MD

Fighting Diseases

Beyond Insulin: Beyond BRI's Quest to Stop Type 1 Diabetes

Get an insider’s look at the past century of T1D research and learn what’s next on BRI’s quest to stop the disease.
Fighting Diseases

New Drug Aims to Retrain the Immune System in T1D

The TOPPLE study is exploring a new T1D treatment that aims to retrain the immune system.
Fighting Diseases

Testing a Vaccine That's Changing the World

Meet the incredible team behind the Pfizer vaccine clinical trial site at BRI.
Subscribe to RSS - Carla Greenbaum MD

What is BRI

  • About the Institute
  • Disease Information
  • Scientists & Labs

Our Research

  • Diabetes Research
  • Biorepositories
  • Programs
  • Publications
  • Clinical Research

Newsroom

  • Autoimmune Life Blog
  • Announcements
  • In the News
  • Press Releases

Resources

  • Contact Info
  • Sign Up
  • Careers
  • Educational Opportunities
  • Community Involvement

Support

  • BRI Events
  • Become a Champion
  • Ways to Give
  • Fundraise for BRI
  • Donate Now

Terms of Use Privacy Policy

© 2023 Benaroya Research Institute | 1201 Ninth Avenue, Seattle, WA 98101-2795

(206) 342-6500

  • Twitter
  • Facebook
  • LinkedIn
  • YouTube
  • Instagram